Table 4 Statistical network models of drawbacks and benefits associated with collaboration across the discovery-development-delivery continuum in a network of organizations working on cancer

-.90 (.18)*

−5.71 (2.24)*

−8.44 (1.52)*

−1.04 (.18)*

−3.83 (1.79)*

−5.69 (1.41)*

-.84 (.18)

−3.84 (1.75)*

−2.57 (3.80)

0.06 (0.05)

.08 (.02)*

na

na

na

na

na

na

0.08 (0.03)*

.02 (.04)

na

na

na

na

na

na

−0.05 (0.03)

.51 (.06)*

−3.03 (3.86)

−2.36 (.77)*

−5.11 (1.55)*

-.52 (.85)

−4.2 (2.21)

21.06 (8.85)*

3.63 (2.07)

2.74 (.06)*

1.87 (1.45)

6.86 (.08)*

1.58 (1.68)

39.22 (.15)

−1.95 (2.04)

−1.39 (.06)*

−1.69 (0.64)*

−1.61 (.08)*

−0.15 (1.23)

−22.56 (.17)*

−5.07 (2.90)

−5.55 (.06)*

−5.63 (1.92)*

−3.21 (.10)*

−12.14 (3.45)*

24.88 (1.27)*

1.33 (1.37)

2.06 (.07)*

−1.15 (1.18)

.86 (.08)*

−1.31 (1.14)

20.43 (.14)*

7.55 (6.09)

6.78 (.06)*

12.72 (4.03)*

−2.23 (.09)*

25.43 (7.5)*

−138.47 (.15)

−2.5 (1.64)

−2.44 (.07)*

−2.29 (1.14)*

.33 (.09)*

−4.61 (1.56)*

17.19 (.16)*

−1.1 (1.41)

−1.52 (.57)*

1.1 (0.69)

-.04 (.93)

−2.87 (0.81)*

.04 (2.71)

2.48 (1.73)

2.41 (.08)*

2.1 (1.11)

-.13 (.09)

4.78 (1.55)*

−8.30 (2.20)*

3.15 (1.92)

2.82 (.49)*

2.76 (1.41)

-3.30 (1.07)*

9.48 (2.98)*

−58.55 (8.72)*

0.74 (2.05)

.93 (.14)*

−1.43 (1.13)

.13 (.66)

−1.75 (1.35)

-.35 (7.94)

1.35 (1.57)

1.99 (.62)*

−0.14 (1.14)

-.78 (1.21)

5.19 (1.52)*

−8.65 (8.19)

−2.02 (1.62)

−2.18 (.71)*

−1.38 (1.04)

1.57 (.70)

−9.16 (2.31)*

31.84 (4.60)*

−4.63 (1.20)*

−4.30 (.38)*

−3.98 (1.04)*

1.30 (.80)

−8.17 (2.28)*

44.04 (7.45)*

na

na

−17.54 (2.38)*

na

1.10 (.10)*

17.49 (.42)

1.59 (.09)*

-.22 (.09)*

−5.45 (.22)